Ginkgo Bioworks (NYSE: DNA) is a cell programming company that claims to have large addressable markets (for bioengineered products) in multiple industries in which it can play a key role, and that those are worth trillions of dollars in total. But the problem is it may take more than a decade for those markets to reach that kind of size. Investors could require a lot of patience.
Open FlipInfibeam Avenues Q4 Results Live : Infibeam Avenues declared their Q4 results on 16 May, 2024. The topline increased by 11.37% & the profit increased by 26.36% YoY. As compared to the previous quarter the revenue declined by 20.3% and the profit increased by 19.86%.The Selling, general & administrative expenses declined by 4.31% q-o-q & increased by 7.53% Y-o-Y.
Open FlipCybersecurity is a massive industry that has never been more important. Hackers are more adept at breaching systems and causing havoc for companies. Precautions must be taken to protect internal and customer data.This requires implementing one (or several) cybersecurity solutions, and, as a result, investors should consider adding cybersecurity stocks to their portfolio.
Open Flip